Bortz, D., Wu, H., Schwarcz, R., & Bruno, J. (2017). Oral Administration of a Specific Kynurenic Acid Synthesis (KAT II) Inhibitor Attenuates Evoked Glutamate Release in Rat Prefrontal Cortex. Neuropharmacology.
Styl ChicagoBortz, D.M., H-Q Wu, R. Schwarcz, a J.P Bruno. "Oral Administration of a Specific Kynurenic Acid Synthesis (KAT II) Inhibitor Attenuates Evoked Glutamate Release in Rat Prefrontal Cortex." Neuropharmacology 2017.
Citace podle MLABortz, D.M., H-Q Wu, R. Schwarcz, a J.P Bruno. "Oral Administration of a Specific Kynurenic Acid Synthesis (KAT II) Inhibitor Attenuates Evoked Glutamate Release in Rat Prefrontal Cortex." Neuropharmacology 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..